HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · IEX Real-Time Price · USD
18.56
+0.55 (3.05%)
At close: Jul 26, 2024, 4:00 PM
18.00
-0.56 (-3.02%)
After-hours: Jul 26, 2024, 7:16 PM EDT

HUTCHMED (China) Revenue

In the year 2023, HUTCHMED (China) had annual revenue of $838.00M with 96.52% growth. HUTCHMED (China) had revenue of $305.13M in the half year ending December 31, 2023, with 53.51% growth.

Revenue (ttm)
$838.00M
Revenue Growth
+96.52%
P/S Ratio
3.86
Revenue / Employee
$421,529
Employees
1,988
Market Cap
3.23B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023838.00M411.59M96.52%
Dec 31, 2022426.41M70.28M19.73%
Dec 31, 2021356.13M128.15M56.21%
Dec 31, 2020227.98M23.09M11.27%
Dec 31, 2019204.89M-9.22M-4.31%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oscar Health 6.54B
ICU Medical 2.26B
Amedisys 2.25B
ACADIA Pharmaceuticals 813.81M
GoodRx Holdings 764.16M
Azenta 651.76M
Inari Medical 520.66M
Amicus Therapeutics 423.49M
Revenue Rankings